Role of endogenous glucagon-like peptide-1 in the serum triglyceride response to intraduodenal fat infusion in type 2 diabetic patients on vildagliptin

被引：0
|
作者：
Wu, T. [1 ,2 ]
Xie, C. [1 ]
Wang, X. [1 ,2 ]
Bound, M. J. [1 ]
Grivell, J. [1 ]
Jones, K. L. [1 ]
Horowitz, M. [1 ]
Little, T. J. [1 ]
Rayner, C. K. [1 ]
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Southeast Univ, Nanjing, Peoples R China
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
579
引用
下载
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [21] Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects
    Vilsboll, T
    Agerso, H
    Krarup, T
    Holst, JJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01): : 220 - 224
  • [22] THE GLUCAGON-LIKE PEPTIDE-1 ANALOGUES THERAPY IN THE NON-DIABETIC PATIENTS
    Sienicka, Agnieszka
    Kubasik, Krzysztof
    Pisula, Agata
    PROSPECTS IN PHARMACEUTICAL SCIENCES, 2023, (01): : 9 - 15
  • [23] Glucagon-like peptide-1 therapy for youth with type 2 diabetes
    Cho, Young Min
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (03) : 362 - 363
  • [24] Impaired postprandial release of glucagon-like peptide-1 in patients with Type 2 diabetes
    Lindqvist, J
    Pigon, J
    Holst, JJ
    Efendic, S
    DIABETOLOGIA, 1998, 41 : A184 - A184
  • [25] Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy
    De León, DD
    Deng, SP
    Madani, R
    Ahima, RS
    Drucker, DJ
    Stoffers, DA
    DIABETES, 2003, 52 (02) : 365 - 371
  • [26] Relationship between meal induced glucagon-like peptide-1 response and metabolic syndrome prevalence in type 1 diabetic patients
    Duvnjak, L.
    Blaslov, K.
    Bulum, T.
    Knezevic-Cuca, J.
    DIABETOLOGIA, 2014, 57 : S220 - S220
  • [27] Effectiveness of glucagon-like peptide-1 agonists in type 2 diabetes
    Pavlicek, Vojtech
    DIABETOLOGIE, 2023, 19 (03): : 359 - 360
  • [28] Effect of Glucagon-Like Peptide-1 on α- and β-Cell Function in C-Peptide-Negative Type 1 Diabetic Patients
    Kielgast, Urd
    Asmar, Meena
    Madsbad, Sten
    Holst, Jens J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (05): : 2492 - 2496
  • [29] Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
    Toft-Nielsen, MB
    Madsbad, S
    Holst, JJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08): : 3853 - 3860
  • [30] Therapeutics Glucagon-like peptide-1 analogues for type 2 diabetes
    Wilding, John P. H.
    Hardy, Kevin
    BRITISH MEDICAL JOURNAL, 2011, 342 : 433 - 435
12345